Raymond James Financial
OLMA icon

Raymond James Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Raymond James Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
20,700
+100
+0.5% +$1.34K ﹤0.01% 4911
2026
Q1 		$307K Sell
20,600
-20,047
-49% -$446K ﹤0.01% 4648
2025
Q4 		$1.02M Buy
+40,647
New +$723K ﹤0.01% 3759

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Raymond James Financial's OLMA Position: Q2 2026 in Review

Raymond James Financial increased its Olema Pharmaceuticals (OLMA) stake by 0.49% in Q2 2026, buying an estimated $1.34K and bringing the position to 20,700 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #4911.

Raymond James Financial first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.02M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Raymond James Financial held 20,700 shares of Olema Pharmaceuticals worth $259K as of Q2 2026.
  • Raymond James Financial bought 100 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.34K.
  • Olema Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4911 holding.
  • Raymond James Financial first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Raymond James Financial's Olema Pharmaceuticals position peaked at $1.02M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.